Brain-derived neurotrophic factor rescues neuronal death induced by methamphetamine

Biological Psychiatry

Volumn 55, Issue 1, 2004, Pages 52-60

  Matsuzaki, Hideo ^a   Namikawa, Kazuhiko ^b   Kiyama, Hiroshi ^b   Mori, Norio ^a   Sato, Kohji ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Akt; Apoptosis; Brain derived neurotrophic factor; Methamphetamine; Mitogen activated protein kinase; Phosphatidylinositol 3 kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; BRAIN DERIVED NEUROTROPHIC FACTOR; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0346422383     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00785-6     Document Type: Article

References (65)

1. Acheson A., Conover J.C., Fandl J.P., DeChiara T.M., Russell M., Thadani A., et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 374:1995;450-453.
2. Ali S.F., Newport G.D., Holson R.R., Slikker W. Jr, Bowuer J.F. Low environmental temperatures of pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658:1994;33-38.
3. Baberg H.T., Nelesen R.A., Dimasdale J.E. Amphetamine use Return of an old scourge in a consultation psychiatry setting . Am J Pshyciatry. 153:1996;789-793.
4. Barbacid M. Neurotrophic factors and their receptors. Curr Opin Cell Biol. 7:1995;148-155.
5. Bonni A. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1999;1358-1362.
6. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;858-868.
7. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol 3-kinase signal transduction. Nature. 376:1995;599-602.
8. Cadet J.L., Ali S.F., Rothman R.B., Epstein C.J. Neurotoxicity, drugs and abuse and the CuZn-superoxide dismutase transgenic mice. Mol Neurobiol. 11:1995;155-163.
9. Cadet J.L., Ordonez S.V., Ordonez J.V. Methamphetamine induces apoptosis in immortalized neural cells Protection by the proto-oncogene, bcl-2 . Synapse. 25:1997;176-184.
10. Cadet J.L., Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int. 32:1998;117-131.
11. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
12. Cass W.A. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. J Neurosci. 16:1996;8132-8139.
13. Cheng B., Mattson M.P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640:1994;56-67.
14. Courtney M.J., Akerman K.E., Coffey E.T. Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism. J Neurosci. 17:1997;4201-4211.
15. Cross D.A., Alessi D.R., Cohen P., Andjelkovic M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
16. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci. 14:1994;2260-2271.
17. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
18. Deng X., Cadet J.L. Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice. Brain Res. 83:2000;121-124.
19. Deng X., Cai N.S., McCoy M.T., Chen W., Trush M.A., Cadet J.L. Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology. 42:2002;837-845.
20. Deng X., Ladenheim B., Tsao L.I., Cadet J.L. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci. 19:1999;10107-10115.
21. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., et al. Regulation of neuronal survival by the serine/threonine protein kinase Akt. Science. 275:1997;661-665.
22. Eisch A.J., Marshall J.F. Methamphetamine neurotoxicity Dissociation of striatal dopamine terminal damage from parietal cortical cell body injury . Synapse. 30:1998;433-445.
23. Ernst T., Chang L., Leonido-Yee M., Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse A 1H MRS study . Neurology. 54:2000;1344-1349.
24. Figueroa-Masot X.A., Hetman M., Higgins M.J., Kokot N., Xia Z. Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation. J Neurosci. 21:2001;4657-4667.
25. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:1995;727-736.
26. Fumagalli F., Gainetdinov R.R., Wang Y.M., Valenzano K.J., Miller G.W., Caron M.G. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci. 19:1999;2424-2431.
27. Gunn-Moore F.J., Williams A.G., Toms N.J., Tavare J.M. Activation of mitogen-activated protein kinase and p70S6 kinase is not correlated with cerebellar granule cell survival. Biochem J. 324:1997;365-369.
28. Han B.H. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci. 20:2000;5775-5781.
29. Hetman M., Cavanaugh J.E., Kimelman D., Xia Z. Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J Neurosci. 20:2000;2567-2574.
30. Hetman M., Kanning K. Neuroprotection by brain-derived neutrotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem. 274:1999;22569-22580.
31. Hetman M., Xia Z. Signaling pathways mediating anti-apoptotic action of neurotrophins. Acta Neurobiol Exp (Warsaw). 60:2000;531-545.
32. Hirata H., Cadet J.L. P53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies. J Neurochem. 69:1997;780-790.
33. Jayanthi S., Deng X., Bordelon M., McCoy M.T., Cadet J.L. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocrtex. FASEB J. 15:2001;1745-1752.
34. Klocker N., Kermer P., Weishaupt J.H., Labes M., Ankerhold R., Bahr M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol- 3′-kinase/protein kinase B signaling. J Neurosci. 20:2000;6962-6967.
35. Kume T., Kouchiyama H., Kaneko S., Maeda T., Akaike A., Shimohama S., et al. BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Res. 756:1997;200-204.
36. Lindholm D., Dechant G., Heisenberg C.P., Thonen H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J Neurosci. 5:1993;1455-1464.
37. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 15:1995;7929-7939.
38. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., et al. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J Neurochem. 73:1999;2037-2046.
39. Melega W.P., Lacan G., Desalles A.A., Phelps M.E. Long-term methamphetamine-induced decreases of [(11)C]WIN35,428 binding in striatum are reduced by GDNF PET studies in the vervet monkey . Synapse. 15:2000;243-249.
40. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-200.
41. Nordahl T.E., Salo R., Possin K., Gibson D.R., Flynn N., Leamon M., et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects A preliminary proton MRS study . Psychiatry Res. 116:2002;43-52.
42. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther. 270:1994;741-751.
43. Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science. 278:1997;687-689.
44. Preston K.L., Wagner G.C., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on monamine neurons in the rhesus monkey brain. Brain Res. 338:1985;243-248.
45. Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain A regional study . Brain Res. 193:1980;153-163.
46. Romashkova J.A., Makarov S.S. NF-kB is a target of AKT in anti-apoptotic PDGF signaling. Nature. 401:1999;86-90.
47. Schmued L.C., Bowyer J.F. Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res. 759:1997;135-140.
48. Sekine Y., Iyo M., Ouchi Y., Matsunaga T., Tsukada H., Okada H., et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 158:2001;1206-1214.
49. Shaw K.P. Human methamphetamine-related fatalities in Taiwan during 1991-1996. J Forensic Sci. 44:1999;27-31.
50. Shimohama S., Tamura Y., Akaike A., Tsukahara T., Ohara O., Watanabe S., et al. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci Lett. 164:1993;55-58.
51. +-induced apoptosis of cerebellar neurons. Brain Res Dev Brain Res. 101:1997;197-206.
52. Skaper S.D., Floreani M., Negro A., Facci L., Giusti P. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway . J Neurochem. 70:1998;1859-1868.
53. Steranka L.R., Sanders-Bush E. Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. Eur J Pharmacol. 65:1980;439-443.
54. Stumm G., Schlegel J., Schäfer T., Würz C., Mennel H.D., Krieg J.C., et al. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13:1999;1065-1072.
55. Tamatani M., Ogawa S., Niitsu Y., Tohyama M. Involvement of Bcl-2 family and caspase-3-like protease in MA-mediated neuronal apoptosis. J Neurochem. 71:1998;1588-1596.
56. Vedder H., Weiss I., Holshore F., Reul J.M. Glucocorticoid and mineralcorticoid receptors in rat neocortical and hippocampal brain cells in culture Characterization and regulatory studies . Brain Res. 605:1993;18-24.
57. Ventimiglia R., Mather P.E., Jones B.E., Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci. 7:1995;213-222.
58. Villemagne V., Yuan J., Wong D.F., Dannals R.F., Hatzidimitriou G., Mathews W.B., et al. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations . J Neurosci. 18:1998;419-427.
59. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M.J., et al. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry. 158:2001;383-389.
60. Wang W., Salvaterra P.M., Loera S., Chiu A.Y. Brain-derived neurotrophic factor spares choline acetyltransferase mRNA following axotomy of motor neurons in vivo. J Neurosci Res. 47:1997;134-143.
61. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med. 2:1996;699-703.
62. Woolverton W.L., Cervo L., Johanson C.E. Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav. 21:1984;737-741.
63. Yamaguchi A., Tamatani M., Matsuzaki H., Namikawa K., Kiyama H., Vitek M.P., et al. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem. 276:2001;5256-5264.
64. Yang E., Zha J., Jock J., Bois L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
65. Yuan J., Callahan B.T., McCann U.D., Ricaurte G.A. Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. J Neurochem. 77:2001;1338-1347.